Banner

Isoflurane Provides Better Myocardial Protection than Midazolam in Pediatric Patients during Open Heart Surgeries

• 2007
Back
Publication Information
Authors Amr Keera MD†, Abd El- Hay MD, Doaa M Ghazy MD* & Mohamed Shehata MD*
Keywords Isoflurane, Myocardial Protection, Midazolam, Pediatric, Open Heart
Journal Not Available
Publisher Not Available
Volume Not Available
Issue Not Available
Pages Not Available
publication.type International
Paper Link Not Available
Supplementary Materials Not Available
Abstract
Objectives: This study was designed to evaluate the applicability of anesthetic myocardial protection (pre-conditioning and minimization of reperfusion injury) using two anesthetic regimens on plasma levels of cardiac troponin T (cTnT), as a marker of myocardial ischemia, in pediatric patients assigned for surgical correction of congenital heart diseases using cardiopulmonary bypass (CPB).
Patients & Methods: The study included 60 patients (36 males and 24 females). Patients were randomly allocated in 2 equal groups: Midazolam group received a continuous infusion of midazolam (0.2 mg/kg/hour) and Isoflurane group maintained by an end-tidal concentration of isoflurane of 1-1.5% throughout the operation. Six blood samples were taken for estimation of plasma cTnT levels immediately after induction of anesthesia, (S1), 8-hours (S2), 16-hours (S3), 24-hours (S4), 36-hours (S5) and 48-hours (S6) after aortic cross-clamping.
Results: Plasma cTnT levels estimated after aortic cross-clamping (S2-S6) showed a significant (P1